Washington, D.C. FDA and Life Sciences partner Eva Temkin will speak at the World Biosimilars Congress on March 20 on Legal Consideration on Interchangeability.  She spoke about statutory and regulatory requirements related to biosimilarity and interchangeability, recent FDA activity, and ongoing issues related to biosimilar development.